Home / Recalls / Cantrell Drug Company / D-0187-2017

D-0187-2017 Class II Terminated

Recalled by Cantrell Drug Company — Little Rock, AR

FDA drug recall D-0187-2017 was initiated by Cantrell Drug Company on November 18, 2016 and is designated Class II. Reason for recall: Lack of Assurance of Sterility - the firm is recalling select sterile drug products. The recall status is terminated (terminated April 29, 2020). Affected quantity: 645 vials.

Recall Details

Product Type
Drugs
Report Date
December 21, 2016
Initiation Date
November 18, 2016
Termination Date
April 29, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
645 vials

Product Description

Calcium Chloride, (1 g/10 mL) Injection Solution 10 mL, 10% Single-Dose Vial, Rx Only, Cantrell Drug Co. 7321 Cantrell Road Little Rock, AR 72207

Reason for Recall

Lack of Assurance of Sterility - the firm is recalling select sterile drug products.

Distribution Pattern

Nationwide

Code Information

Lot: 169924

Other recalls by Cantrell Drug Company

  • D-1079-2017 Class II — Rocuronium Bromide Injection Solution 5 mL, 50 mg/5 mL (10 mg/mL) Single-Dose Sy (July 14, 2017)
  • D-1066-2017 Class II — Glycopyrrolate Injection Solution, 2 mL 0.4 mg/2 mL (0.2 mg/mL) Single-Dose Syri (July 14, 2017)
  • D-1073-2017 Class II — Diltiazem HCl 125 mg in 5% Dextrose 125 mL Single-Dose- Bag, Rx Only, Cantrell (July 14, 2017)
  • D-1070-2017 Class II — Norepinephrine Bitartrate 8 mg Added to 0.9% Sodium Chloride 250 mL (32 mcg per (July 14, 2017)
  • D-1062-2017 Class II — Ephedrine Sulfate in 0.9% Sodium Chloride 5 mL, 25 mg/5 mL (5 mg/mL) Single-Dose (July 14, 2017)
  • D-1076-2017 Class II — Adenosine in 0.9% Sodium Chloride 30mL, 90 mg/30 mL (3 mg/mL) Single-Dose Syring (July 14, 2017)
  • D-1075-2017 Class II — Sodium Bicarbonate 8.4% Injection Solution 50 mL, 50 mEq (1mEq/mL) Single-Dose S (July 14, 2017)
  • D-1068-2017 Class II — Succinylcholine Chloride Injection Solution 10 mL, 200 mg/10 mL (20 mg/mL) Singl (July 14, 2017)
  • D-1063-2017 Class II — Ephedrine Sulfate Injection Solution 1 mL, 50 mg/1 mL (50 mg/mL) Single-Dose Sy (July 14, 2017)
  • D-1065-2017 Class II — Glycopyrrolate Injection Solution, 5 mL 1 mg/5 mL (0.2 mg/mL) Single-Dose Syring (July 14, 2017)

FDA data resources